Risk factors
Cerenome (CNSY) risk factors
Item 1A of every Cerenome, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors79 risks14 new6 dropped14 reworded
Nasdaq listing and delisting risks now dominate, with separate equity and bid-price compliance deadlines extending into 2026.
Filed Mar 12, 2026 - FY2024 10-K risk factors71 risks
Operating losses of $13.0 million in 2024 and accumulated deficit of $493.5 million threaten going concern status. Reliance on CPRIT and DoD grant funding introduces strict government oversight and repayment terms. Shifting FDA regulation of 188RNL-BAM to a medical device creates new compliance hurdles.
Filed Mar 31, 2025